Double-blind, placebo-controlled, crossover trial of propranolol as treatment for menopausal vasomotor symptoms

J. M. Alcoff, D. Campbell, D. Tribble, B. Oldfield, D. Cruess

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

A trial of propranolol for the treatment of vasomotor symptoms was conducted among 37 menopausal women in a double-blind, placebo-controlled, crossover fashion. When compared with placebo, propranolol had a statistically significant effect on the reduction of both the frequency and severity of vasomotor symptoms (P<0.01). In selected patients, propranolol may be an alternative to the treatment of vasomotor symptoms with exogenous estrogens.

Original languageEnglish
Pages (from-to)356-364
Number of pages9
JournalClinical Therapeutics
Volume3
Issue number5
StatePublished - 1981

Fingerprint

Dive into the research topics of 'Double-blind, placebo-controlled, crossover trial of propranolol as treatment for menopausal vasomotor symptoms'. Together they form a unique fingerprint.

Cite this